Education
About Us
Working with TipRanks
Follow Us
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
BCLI Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Maxim Group
$10
Buy
740.34%
Upside
Reiterated
12/12/24
Analysts Offer Insights on Healthcare Companies: Opus Genetics (NASDAQ: IRD) and Brainstorm Cell Therapeutics (NASDAQ: BCLI)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Maxim Group
$10
Buy
740.34%
Upside
Reiterated
12/12/24
Analysts Offer Insights on Healthcare Companies: Opus Genetics (NASDAQ: IRD) and Brainstorm Cell Therapeutics (NASDAQ: BCLI)
BCLI Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Dec 24
Strong Buy
1
2
3
2
2
Buy
0
0
0
1
1
Hold
2
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
BCLI Stock Forecast FAQ
What is BCLI’s average 12-month price target, according to analysts?
Based on analyst ratings, Brainstorm Cell Therapeutics’s 12-month average price target is $10.00.
What is BCLI’s upside potential, based on the analysts’ average price target?
Brainstorm Cell Therapeutics has 740.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BCLI a Buy, Sell or Hold?
Brainstorm Cell Therapeutics has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Brainstorm Cell Therapeutics’s price target?
The average price target for Brainstorm Cell Therapeutics is $10.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.00 ,the lowest forecast is $10.00. The average price target represents 740.34% Increase from the current price of $1.19.
The highest analyst price target is $10.00 ,the lowest forecast is $10.00. The average price target represents 740.34% Increase from the current price of $1.19.
What do analysts say about Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of BCLI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.